Today: 19 March 2026
Browse Category

Stock Market 22 December 2025

Rocket Lab (RKLB) Stock: Space Force Satellite Deal, Record Electron Launches, Neutron Timeline, and Wall Street Forecasts Ahead of the Dec. 22, 2025 Market Open

Rocket Lab (RKLB) Stock: Space Force Satellite Deal, Record Electron Launches, Neutron Timeline, and Wall Street Forecasts Ahead of the Dec. 22, 2025 Market Open

Rocket Lab announced an $816 million U.S. Space Development Agency contract on Dec. 19 to build 18 missile warning satellites, its largest SDA award to date. The deal could bring Rocket Lab’s total program value to about $1 billion, with subsystem opportunities included. The company’s contracted backlog reportedly jumped to around $1.1 billion after the win. Deployment of the satellites is expected by 2029.
Warner Bros. Discovery (WBD) Stock: Netflix Deal, Paramount Bid, and Key Numbers to Watch Before the Market Opens on Dec. 22, 2025

Warner Bros. Discovery (WBD) Stock: Netflix Deal, Paramount Bid, and Key Numbers to Watch Before the Market Opens on Dec. 22, 2025

WBD shares closed near $27.77 ahead of Monday’s open, tracking the value of competing takeover bids from Netflix and Paramount Skydance. Netflix has offered $27.75 per share in cash and stock, while Paramount is pitching a $30 all-cash deal. The stock price reflects investor bets on which bid will prevail. Regulatory review and deal terms remain in focus.
Palo Alto Networks (PANW) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025

Palo Alto Networks (PANW) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025

Palo Alto Networks and Google Cloud have expanded their partnership in a security services deal reportedly worth nearly $10 billion over several years, Reuters reported Dec. 19. PANW shares last closed at $186.88. The agreement includes AI-driven cybersecurity initiatives and deeper integration of Palo Alto’s platforms with Google Cloud services. Investors are watching for further details on margins and execution.
22 December 2025
Merck (MRK) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Merck (MRK) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Merck announced a new U.S. drug-pricing agreement, pledging to offer Januvia and related diabetes drugs at about 70% off list prices through a direct-to-patient program. The company also reached a deal with the Commerce Department to delay Section 232 tariffs for three years. Merck shares closed at $101.09, near the top of their 52-week range. The next earnings report is expected in early February 2026.
22 December 2025
Home Depot Stock (HD): What Investors Should Know Before the Market Opens on Dec. 22, 2025

Home Depot Stock (HD): What Investors Should Know Before the Market Opens on Dec. 22, 2025

Home Depot shares closed at $345.00 Friday, down 2.8%, after the company reaffirmed fiscal 2025 guidance and issued a cautious 2026 outlook with projected total sales growth of 2.5% to 4.5%. Management emphasized a shift toward Pro customers and productivity. Housing market data showed modest improvement but ongoing constraints. A reported security issue involving leaked credentials also surfaced.
22 December 2025
Qualcomm (QCOM) Stock: What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Earnings Forecasts, and Analyst Outlook

Qualcomm (QCOM) Stock: What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Earnings Forecasts, and Analyst Outlook

Qualcomm closed at $175.25 on Dec. 19, 2025, with after-hours trading at $175.75 and a market cap near $186 billion. The company completed its Alphawave Semi acquisition on Dec. 18, accelerating its data center AI push. Tony Pialis, Alphawave’s CEO, will lead Qualcomm’s data center business. Next earnings are scheduled for Feb. 4, 2026.
Bank of America (BAC) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Bank of America (BAC) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Bank of America shares closed Friday at $55.27, up 1.86% on heavy volume ahead of the holiday week. Oppenheimer raised its price target to $63 from $55, maintaining an “outperform” rating. The next earnings report is set for Jan. 14, with analysts expecting Q4 EPS of about $0.96, up from $0.82 a year ago. CEO Brian Moynihan recently signaled potential high single-digit to 10% growth in trading revenue for Q4.
22 December 2025
Goldman Sachs Stock (GS): What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Analyst Forecasts, and Key Catalysts

Goldman Sachs Stock (GS): What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Analyst Forecasts, and Key Catalysts

Goldman Sachs closed at $893.48 on Dec. 19, near its 52-week high of $919. Wall Street rates the stock “Hold” with a mean 1-year price target of $793. The firm’s Q4 2025 earnings are scheduled for Jan. 15, 2026. Goldman has reorganized its investment-banking teams around AI and digital infrastructure and agreed to acquire Innovator Capital Management.
22 December 2025
Citigroup (C) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Citigroup (C) Stock: What to Know Before the Market Opens on Dec. 22, 2025

Citigroup shares closed at $114.86 on Friday, near 2025 highs, as investors weighed recent regulatory relief. The Federal Reserve ended three confidential supervisory actions tied to trading risk, and the OCC removed a 2024 amendment to Citi’s 2020 consent order. Citi’s Q4 earnings are set for Jan. 14, 2026. The underlying 2020 consent order remains in effect.
22 December 2025
AbbVie Stock (ABBV) Before the Market Opens on Dec. 22, 2025: Drug-Pricing Talks, Dividend Signals, and the Next Catalysts

AbbVie Stock (ABBV) Before the Market Opens on Dec. 22, 2025: Drug-Pricing Talks, Dividend Signals, and the Next Catalysts

AbbVie closed at $226.82 on Friday, Dec. 19, up 1.8%, with trading volume spiking to 18.6 million shares, well above average. The company remains in talks with the White House as U.S. drug pricing reforms accelerate, including “most-favored-nation” deals and new TrumpRx programs. AbbVie is expected to visit the White House after the holidays for further negotiations.
Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Alnylam Pharmaceuticals joins the Nasdaq-100 before the U.S. market opens Dec. 22, prompting index-tracking funds to adjust positions. Shares last closed at $400.23. The company’s drug Amvuttra recently secured routine NHS use in England and Health Canada approval for ATTR cardiomyopathy. Alnylam also announced a $250 million manufacturing expansion and new FDA recognition for its technology platform.
Exxon Mobil (XOM) Stock: Key News, Analyst Forecasts, and What to Watch Before the U.S. Market Opens on Dec. 22, 2025

Exxon Mobil (XOM) Stock: Key News, Analyst Forecasts, and What to Watch Before the U.S. Market Opens on Dec. 22, 2025

Exxon Mobil shares last traded at $116.69, down 1.02%, as crude prices hover near multi-year lows. Oil rebounded early Dec. 22 after the U.S. intercepted a Venezuelan tanker, but remains volatile. Exxon updated its 2030 plan, targeting $25 billion earnings growth and raising output goals. CFO Kathy Mikells will retire Feb. 1, 2026, with Neil Hansen set to succeed her.
22 December 2025
Salesforce Stock (NYSE: CRM): Key News, Analyst Forecasts, and What to Watch Before the U.S. Market Opens on Dec. 22, 2025

Salesforce Stock (NYSE: CRM): Key News, Analyst Forecasts, and What to Watch Before the U.S. Market Opens on Dec. 22, 2025

Salesforce shares closed at $259.91 on Dec. 19, down nearly 21% year-to-date but up 14.6% for the month. The company announced a deal to acquire Qualified, an AI marketing firm, on Dec. 17. In its latest earnings, Salesforce reported Q3 revenue of $10.3 billion, up 9% year-over-year, and highlighted Agentforce and Data 360 annualized revenue reaching $1.4 billion, up 114%.
22 December 2025
AppLovin (NASDAQ: APP) Stock Preview: Key News, Analyst Targets, Financial Outlook, and Risks to Watch Before the Market Opens on Dec. 22, 2025

AppLovin (NASDAQ: APP) Stock Preview: Key News, Analyst Targets, Financial Outlook, and Risks to Watch Before the Market Opens on Dec. 22, 2025

AppLovin closed Friday at $721.37, up nearly 4%, with after-hours trading near $725. The company’s market cap stands at about $243.8 billion. AppLovin now operates solely as an advertising/software platform after selling its Apps Business on June 30, 2025. The stock faces ongoing short-seller scrutiny and reported regulatory attention over data practices.
22 December 2025
Nike (NKE) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025 — Earnings Fallout, China Risks, Tariffs, and Wall Street Forecasts

Nike (NKE) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025 — Earnings Fallout, China Risks, Tariffs, and Wall Street Forecasts

Nike shares closed at $58.71 on Friday, down 11% after a post-earnings selloff and hitting a seven-month low. Net income and EPS fell 32% in fiscal Q2 2026 despite a revenue increase, with margins pressured by tariffs and ongoing weakness in China. Wholesale revenue rose, but direct-to-consumer sales dropped. Analysts trimmed price targets, citing tariff risks and China uncertainty.

Stock Market Today

  • Lean Hog Futures Close Mixed as Pork Cutout Value Rises
    March 18, 2026, 8:36 PM EDT. Lean hog futures showed a mixed close Wednesday, with front-month contracts gaining 37 to 97 cents while back months fell 20 to 55 cents. The national average base hog price rose 24 cents to $78.03. The CME Lean Hog Index, reflecting average cash prices, increased 14 cents to $83.98 on Dec. 16. The USDA reported a higher pork cutout value at $96.35 per hundredweight, up $1.58, driven by moderate gains in some primals despite slight declines in loin, butt, and picnic cuts. Hog slaughter was estimated at 488,000 head, slightly below last week but up from last year. February, April, and May futures closed up by 50, 85, and 97 cents respectively, signaling modest optimism in the market.
Go toTop